This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 May;43(9):1020.

doi: 10.1111/apt.13579.

Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure--authors' reply

J P Gisbert¹, M Chaparro²

Affiliations

Affiliations

¹ Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. javier.p.gisbert@gmail.com.
² Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.

PMID: 27040169
DOI: 10.1111/apt.13579

Comment

Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure--authors' reply

J P Gisbert et al. Aliment Pharmacol Ther. 2016 May.

. 2016 May;43(9):1020.

doi: 10.1111/apt.13579.

Authors

J P Gisbert¹, M Chaparro²

Affiliations

¹ Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. javier.p.gisbert@gmail.com.
² Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.

PMID: 27040169
DOI: 10.1111/apt.13579

No abstract available

PubMed Disclaimer

Comment on

Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed.
Gisbert JP, Marín AC, McNicholl AG, Chaparro M. Gisbert JP, et al. Aliment Pharmacol Ther. 2015 Apr;41(7):613-23. doi: 10.1111/apt.13083. Epub 2015 Feb 4. Aliment Pharmacol Ther. 2015. PMID: 25652884
Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure.
Macaluso FS, Criscuoli V, Orlando E, Rizzuto G, Renna S, Cottone M, Orlando A. Macaluso FS, et al. Aliment Pharmacol Ther. 2016 May;43(9):1019-20. doi: 10.1111/apt.13565. Aliment Pharmacol Ther. 2016. PMID: 27040168 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations